Clinical Trial Update: A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir [Phase 1]

View source ↗

Summary

This document reports a Phase 1 bioequivalence study of daclatasvir tablets and bioavailability studies of daclatasvir and asunaprevir. The sponsor is Bristol-M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Asunaprevir (asunaprevir)
• Daclatasvir (daclatasvir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C Infection | Phase 1 | Status: COMPLETED